Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

G1 Therapeutics initiates phase II trial of Cosela in metastatic bladder cancer

June 15, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

Novadip reports phase I data on first-generation autologous cell-based osteogenic product NVD-001

June 15, 2021

Cocrystal's CDI-45205 shows in vitro activity against SARS-CoV-2 and variants

June 15, 2021

Topline phase Ib data reported on RPT-193 in atopic dermatitis

June 15, 2021

YL-13027 demonstrates safety and preliminary activity in patients with solid tumors

June 15, 2021

BT-200: prolonging half-life of vWF

June 15, 2021

First-in-human data presented for the anti-CD47 MAb AK-117

June 15, 2021

University of Utah divulges TRPV4 antagonists

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...